LustgartenLIVE!

Welcome to LustgartenLIVE!, a new quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer. Moderated by Andrew Rakeman, PhD, Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations.

Hope is on the horizon!

REGISTRATION IS NOW OPEN
for Early Detection: The Path Forward

Noon-1 pm EST
Wednesday, April 21

Though pancreatic cancer is considered a rare disease, it remains the third-leading cause of cancer-related death. Because we know earlier detection plays a key factor in saving and extending lives, the Lustgarten Foundation has designated early detection as a research funding priority.

In this live discussion you’ll have access to the latest information from the lead scientists behind two of the most promising advances in early detection screenings:

Elliot Fishman, MD
Professor of Radiology & Radiological Science, Johns Hopkins

The FELIX Project focuses on using artificial intelligence to develop new early detection methods. Researchers have trained computers to detect pancreatic tumors on CT scans by recognizing patterns in medical images. Work continues to detect tumors so small that they may be missed by the human eye. Earlier detection of these small tumors could allow treatment to begin before the cancer has spread.

Bert Vogelstein, MD
Director of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Laboratory at Johns Hopkins

CancerSEEK is a blood test that can identify the presence of multiple cancers including pancreatic cancer at the earliest possible stages before noticeable symptoms and/or metastasis can occur. Last year, a landmark study of the test showed promising results for earlier detection as part of routine medical checks, which could be a game changer for patients .

Moderated by Andrew Rakeman, PhD, Vice President of Research, Lustgarten Foundation

This LustgartenLIVE! webinar is made possible by the support of Ipsen and Elevation Oncology.

Ipsen Innovation for Patient Care
LFL-spon_EO_Logo_Sk_LG

Thank you to the following donors for supporting the Early Detection Initiative.

Eleanor Schwartz Charitable Foundation
Fight Cancer Stay Positive (FCSP)
The McAdam Family Foundation
Peterson Family Fund

Mark your calendars for the entire LustgartenLIVE! series:

Under the Glass: Behind the Scenes of the Lab

Wednesday, June 30, 2021

David Tuveson, MD, PhD, Chief Scientist and Director of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory

From the Lab to You: Clinical Advances

Wednesday, Sept. 22, 2021

Elizabeth Jaffee, MD, Chief Medical Advisor and Director of the Lustgarten Foundation Clinical Accelerator Initiative
Brian Wolpin, MD, MPH, Director of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Laboratory at Dana-Farber Cancer Institute

The Best of 2021:Research Highlights

Tuesday, Dec. 14, 2021

Elizabeth Jaffee, MD, Chief Medical Advisor and Director of the Lustgarten Foundation Clinical Accelerator Initiative
David Tuveson, MD, PhD, Chief Scientist and Director of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory

For Sponsorship and Program Information:  StephanieD@lustgarten.org or 516-737-1521

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top